0001209191-23-037613.txt : 20230615 0001209191-23-037613.hdr.sgml : 20230615 20230615210029 ACCESSION NUMBER: 0001209191-23-037613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Todd CENTRAL INDEX KEY: 0001711463 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 231019168 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD STREET 2: SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-13 0 0001863127 Tyra Biosciences, Inc. TYRA 0001711463 Harris Todd C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 1 1 0 0 Chief Executive Officer 1 Common Stock 2023-06-13 4 M 0 7927 2.25 A 1709203 D Common Stock 2023-06-13 4 S 0 7927 16.0048 D 1701276 D Common Stock 2023-06-15 4 M 0 12773 2.25 A 1714049 D Common Stock 2023-06-15 4 S 0 12773 16.1275 D 1701276 D Stock Option (Right to Buy) 2.25 2023-06-13 4 M 0 7927 0.00 D 2031-03-09 Common Stock 7927 389610 D Stock Option (Right to Buy) 2.25 2023-06-15 4 M 0 12773 0.00 D 2031-03-09 Common Stock 12773 376837 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. /s/ Ali D. Fawaz, Attorney-in-Fact 2023-06-15